Cited by 333Medication Adherence and ComplianceMobile Health and mHealth ApplicationsBlood Pressure and Hypertension Studies

Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial

Open access
Morawski, Kyle, Ghazinouri, Roya, Krumme, Alexis, Lauffenburger, Julie C., Lu, Zhigang, Durfee, Erin, Oley, Leslie, Lee, Jessica +4 more·2018·JAMA Internal Medicine

Abstract

Importance: Medication nonadherence accounts for up to half of uncontrolled hypertension. Smartphone applications (apps) that aim to improve adherence are widely available but have not been rigorously evaluated. Objective: To determine if the Medisafe smartphone app improves self-reported medication adherence and blood pressure control. Design, Setting, and Participants: This was a 2-arm, randomized clinical trial (Medication Adherence Improvement Support App For Engagement-Blood Pressure [MedISAFE-BP]). Participants were recruited through an online platform and were mailed a home blood pressure cuff to confirm eligibility and to provide follow-up measurements. Of 5577 participants who were screened, 412 completed consent, met inclusion criteria (confirmed uncontrolled hypertension, taking 1 to 3 antihypertensive medications), and were randomized in a ratio of 1:1 to intervention or control. Interventions: Intervention arm participants were instructed to download and use the Medisafe app, which includes reminder alerts, adherence reports, and optional peer support. Main Outcomes and Measures: Co-primary outcomes were change from baseline to 12 weeks in self-reported medication adherence, measured by the Morisky medication adherence scale (MMAS) (range, 0-8, with lower scores indicating lower adherence), and change in systolic blood pressure. Results: Participants (n = 411; 209 in the intervention group and 202 controls) had a mean age of 52.0 years and mean body mass index, calculated as weight in kilograms divided by height in meters squared, of 35.5; 247 (60%) were female, and 103 (25%) were black. After 12 weeks, the mean (SD) score on the MMAS improved by 0.4 (1.5) among intervention participants and remained unchanged among controls (between-group difference: 0.4; 95% CI, 0.1-0.7; P = .01). The mean (SD) systolic blood pressure at baseline was 151.4 (9.0) mm Hg and 151.3 (9.4) mm Hg, among intervention and control participants, respectively. After 12 weeks, the mean (SD) systolic blood pressure decreased by 10.6 (16.0) mm Hg among intervention participants and 10.1 (15.4) mm Hg among controls (between-group difference: -0.5; 95% CI, -3.7 to 2.7; P = .78). Conclusions and Relevance: Among individuals with poorly controlled hypertension, patients randomized to use a smartphone app had a small improvement in self-reported medication adherence but no change in systolic blood pressure compared with controls. Trial Registration: clinicaltrials.gov Identifier: NCT02727543.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2018.0447

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-quality evidence from multicenter randomized controlled trials has recently emerged demonstrating the potential of app-based interventions to improve treatment adherence in the management of hypertension and clinical outcomes from enhanced perioperative care after elective abdominal surgery.

    “High-quality evidence from multicenter randomized controlled trials has recently emerged demonstrating the potential of app-based interventions to improve treatment adherence in the management of hypertension and clinical outcomes from enhanced perioperative care after elective abdominal surgery.”

    From What is the clinical value of mHealth for patients? (2020) · cites this paper as [17]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 32

  1. Benjamin EJ, Blaha MJ, Chiuve SE, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association. Circulation. 2017; 135(10):e146-e603.
  2. Booth JN III, Muntner P, Abdalla M, et al. Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study. J Hypertens. 2016;34(2):235-243.
  3. de Oliveira-Filho AD, Costa FA, Neves SJ, de Lyra Junior DP, Morisky DE. Pseudoresistant hypertension due to poor medication adherence. Int J Cardiol. 2014;172(2):e309-e310.
  4. Rehman H, Kamal AK, Morris PB, Sayani S, Merchant AT, Virani SS. Mobile Health (mHealth) technology for the management of hypertension and hyperlipidemia: slow start but loads of potential. Curr Atheroscler Rep. 2017;19(3):12.
  5. Buis L, Hirzel L, Dawood RM, et al. Text messaging to improve hypertension medication adherence in African Americans from primary care and emergency department settings: results from two randomized feasibility studies. JMIR Mhealth Uhealth. 2017;5(2):e9.
  6. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003). 2013;53(2):172-181.
  7. Dayer LE, Shilling R, Van Valkenburg M, et al. Assessing the medication adherence app marketplace from the health professional and consumer vantage points. JMIR Mhealth Uhealth. 2017;5(4):e45.
  8. Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314 (12):1255-1263.
  9. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176(3):340-349.
  10. Moore JO, Marshall MA, Judge DC, et al. Technology-supported apprenticeship in the management of hypertension: a randomized controlled trial. J Clin Outcomes Manag. 2014;21(3): 110-122.
  11. Morawski K, Ghazinouri R, Krumme A, et al. Rationale and design of the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial. Am Heart J. 2017; 186:40-47.
  12. Oliveria SA, Chen RS, McCarthy BD, Davis CC, Hill MN. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med. 2005;20(3):219-225.
  13. Benetti E, Fania C, Palatini P. Validation of the A&D BP UA-651 device with a wide-range cuff for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit. 2015;20 (3):164-167.
  14. Siu AL; U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778-786.
  15. Santo K, Richtering SS, Chalmers J, Thiagalingam A, Chow CK, Redfern J. Mobile phone apps to improve medication adherence: a systematic stepwise process to identify high-quality apps. JMIR Mhealth Uhealth. 2016;4 (4):e132.
  16. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
  17. Appel LJ, Moore TJ, Obarzanek E, et al; DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117-1124.
  18. Harsha DW, Bray GA. Weight loss and blood pressure control (Pro). Hypertension. 2008;51(6): 1420-1425.
  19. Crim MT, Yoon SS, Ortiz E, et al. National surveillance definitions for hypertension prevalence and control among adults. Circ Cardiovasc Qual Outcomes. 2012;5(3):343-351.
  20. Horton J, Lipsitz R. Multiple imputation in practice. Am Stat. 2001;55(3):244-254.
  21. Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015;314(18):1966-1967.
  22. Mancia G. Short-and long-term blood pressure variability: present and future. Hypertension. 2012; 60(2):512-517.
  23. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3): 185-194.
  24. Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens. 2015;28(10):1209-1221.
  25. Muntner P, Joyce C, Holt E, et al. Defining the minimal detectable change in scores on the eight-item Morisky medication adherence scale. Ann Pharmacother. 2011;45(5):569-575.
  26. Choudhry NK, Glynn RJ, Avorn J, et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014;167(1):51-58.e5.
  27. Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1(7972): 1265-1268.
  28. Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. 2010;28(12):1097-1107.
  29. Margolis KL, Asche SE, Bergdall AR, et al. A successful multifaceted trial to improve hypertension control in primary care: why did it work? J Gen Intern Med. 2015;30(11):1665-1672.
  30. Diaz JA, Griffith RA, Ng JJ, Reinert SE, Friedmann PD, Moulton AW. Patients' use of the internet for medical information. J Gen Intern Med. 2002;17(3):180-185.
  31. Verberk WJ, Kroon AA, Kessels AG, de Leeuw PW. Home blood pressure measurement: a systematic review. J Am Coll Cardiol. 2005;46(5): 743-751.
  32. Linn AJ, Vervloet M, van Dijk L, Smit EG, Van Weert JC. Effects of eHealth interventions on medication adherence: a systematic review of the literature. J Med Internet Res. 2011;13(4):e103.

Cited by

Sorted by citations

Authors
Morawski, K., Ghazinouri, R., Krumme, A., Lauffenburger, J. C., Lu, Z., Durfee, E., Oley, L., Lee, J., Mohta, N., Haff, N., Juusola, J. L., & Choudhry, N. K.
Affiliations
  • Brigham and Women's Hospital (US)
  • Evidation Health (United States) (US)
Corresponding author
Choudhry, Niteesh K.
Venue
JAMA Internal Medicine
Published
2018-06-01
Volume
178
Issue
6
Pages
802
ISSN
2168-6106 (ISSN-L)
OpenAlex
W2799837895
Cited by
333
References
7
Citations by year
2026: 23 · 2025: 48 · 2024: 46 · 2023: 52 · 2022: 35 · 2021: 45 · 2020: 43 · 2019: 28 · 2018: 13
FWCI
36.95
Type
journal article
Language
en
Open access
Locations
  • JAMA Internal Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
mobile application, medication adherence, hypertension, blood pressure control, medication reminders, peer support, antihypertensive drugs, Morisky Medication Adherence Scale, systolic blood pressure, self-reported adherence, digital health interventions, uncontrolled hypertension, medication non-adherence, home blood pressure monitoring, adverse drug reactions, drug costs
MeSH terms
Smartphone, Assessment of Medication Adherence, Adult, Antihypertensive Agents, Blood Pressure, Female, Humans, Hypertension, Male, Middle Aged, Drug Monitoring, Medication Adherence, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review